Cory berkland

Bradley J. Newell. Interim Assistant Dean - Wichita. Director - PGY-1 Community-Based Pharmacy Residency (DIllons) Clinical Assistant Professor. School of Pharmacy - Administration. Department of Pharmacy Practice. Dept. of Family & Community Med., KU Med., Wichita. View full profile.

Cory Berkland, Solon E. Summerfield Distinguished Professor; Stevin Gehrke, Fred Kurata Memorial Professor; Trung Van Nguyen, professor; Mark Shiflett, Foundation Distinguished Professor; Bala Subramaniam, Dan F. Servey Distinguished Professor; Civil, environmental & architectural engineering. David Darwin, Deane E. Ackers Distinguished ProfessorCory Plock was the best professor I had while completing a MS in Computer Science at NYU. He introduced programming languages with a tremendous amount of expertise and compassion. His assignments and exams were very challenging, yet he consistently went above and beyond to provide support, giving guidance and detailed feedback. Thank …Abdulgader Baoum, 1 Sheng-Xue Xie, 1 Amir Fakhari, 2 and Cory Berkland 1, 3, 4 Abdulgader Baoum 1 Department of Pharmaceutical Chemistry, The University of Kansas, 2030 Becker Drive, Lawrence, Kansas 66047, USACory Berkland: Resources, Writing - review & editing. Michael J. Hageman: Writing - review & editing, Project administration, Supervision, Resources. Declaration of Competing Interest. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work …Chuda Chittasupho, 1 Joshua Sestak, 2 Laura Shannon, 3 Teruna J. Siahaan, 2 Charlotte M. Vines, 3 and Cory Berkland 2, 4 Chuda Chittasupho 1 Department of Pharmaceutical Technology, Faculty of Pharmacy, Srinakharinwirot University, 63 Mu 7 Rangsit-Nakhonnayok Road, Ongkharak, Nakhonnayok, 26120, ThailandCory Berkland is a professor of pharmaceutical chemistry and chemical and petroleum engineering at the University of Kansas. (Berkland Tr. 593) The Court recognized Dr. Berkland as an expert in the preparation and analysis of pharmaceutical formulations. (Id. at 594) B. Defendants' Experts.Cory Berkland. Download Free PDF View PDF. Nature Nanotechnology. Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. 2012 • Ciro Chiappini, Michael Evangelopoulos, Lucas Isenhart, Ennio Tasciotti. Download Free PDF View PDF.

Nashwa El-Gendy1,3, Warangkana Pornputtapitak1, and Cory Berkland1,2,* 1Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS 66047. ... Fax: (001) 785- 864- 1454. [email protected]. Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our864-1455, Fax: (785) 864-1454, [email protected]. ‡Authors contributed equally to this work Supporting Information Figure S1. HSQC NMR data for DEX-N3. Figure S2. Levels of IFN-γ at peak of disease. Figure S3. Levels of IL-6 at peak of disease. Figure S4. Levels of IL-15 at peak of disease. Figure S5. Levels of IL-17A at peak of disease ...Conflict of interest C. Berkland has a patent (US 20110287547 A1) on Ca-TAT peptides. These studies were not solicited or funded by any pharmaceutical company. ... Cory Berkland, Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS …Nashwa El-Gendy1,3, Warangkana Pornputtapitak1, and Cory Berkland1,2,* 1Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS 66047. ... Fax: (001) 785- 864- 1454. [email protected]. Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to ourChristian Pharmacists Fellowship International (CPFI) unites pharmacists and pharmacy students working to incorporate their faith into the pharmacy profession. CPFI has chapters throughout the United States and offers members opportunities for community service, short or long term mission trips, bible studies and an annual national conference.Brad Spitz, Nathan Dormer & Cory Berkland are part of Orbis Biosciences leadership, Maria Stecklein Flynn is the CEO.

Cory Berkland, PhD Chief Executive Officer. Dr. Berkland serves as the Chairman of the Board, President, Chief Executive Officer (CEO), and Co-Founder of Bond Biosciences. …Prof. Berkland is a co-founder of Orbis Biosciences, Savara Pharmaceuticals, Bond Biosciences and Orion BioScience. He is also a co-developer of several technologies with industrial partners. He... 2022: Laura Ensign 2021: Helder Santos 2020: Kathryn Whitehead 2019: Jordan Green 2018: Steven R Little 2017: Zhen Gu 2016 Ryan Donnelly 2015 Twan Lammers 2014 Suzie Pun 2013 Ali Khademhosseini 2012 Cory Berkland 2011 Molly Stevens 2010 Krish Roy 2009 Justin Hanes 2008 Samir Mitragotri 2007 David Putnam 2006 Stefaan De Smedt 2005 Mark Prausnitz 2004 Jean-Christophe LerouxMay 4, 2017 · LAWRENCE — Cory Berkland might not be the first person you’d guess would help to create what has become a multimillion-dollar company. The distinguished professor, appointed in the departments of Pharmaceutical Chemistry and Chemical & Petroleum Engineering at the University of Kansas, grew up on a pig farm in Iowa, studied chemical engineering at the undergraduate and graduate levels and ... Jun 6, 2016 · 1. INTRODUCTION. Hyaluronic acid (HA) is a linear biopolymer component of multiple approved products and exhibits versatility for drug delivery, since it is available in a wide range of molecular weights and offers multiple sites for chemical modification. 1–6 In the human body, HA is prevalent in cartilage, skin, and synovial fluid and is typically present as a very high molecular weight ...

Yakuza 0 leisure king properties.

AU - Berkland, Cory. N1 - Funding Information: We gratefully acknowledge support from the National Institute of Allergy and Infectious Diseases at the National Institutes of Health (R56 AI091996), the National Institute of General Medical Sciences (T32 GM008359), the Kansas IDeA Network of Biomedical Research Excellence, the PhRMA Foundation ...Cory Berkland. Download Free PDF View PDF. Nature Nanotechnology. Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. 2012 • Ciro Chiappini, Michael Evangelopoulos, Lucas Isenhart, Ennio Tasciotti. Download Free PDF View PDF.INTRODUCTION. Autoimmune diseases such as multiple sclerosis (MS) are typified by a breakdown of healthy immune regulation and subsequent misrecognition of self for non-self. 1-2 The autoimmune breakdown in MS is largely propagated by autoreactive T and/or B cell clonal expansion and attack against myelin sheath autoantigens, leading to demyelination and neurodegeneration. 3-6 Activation ...Chad Groer 1 , Ti Zhang 1 , Ruolin Lu 2 , Shuang Cai 1 , Derek Mull 1 2 , Aric Huang 2 , Melanie Forrest 1 , Cory Berkland 2 3 , Daniel Aires 1 4 , Marcus Laird Forrest 1 2 Affiliations 1 HylaPharm LLC, 2029 Becker Dr, Lawrence, Kansas 66047, United States.Barlas Büyüktimkin, 1 Qun Wang, 2 Paul Kiptoo, 1 John M. Stewart, 1 Cory Berkland, 1, 2 and Teruna J. Siahaan 1, * Barlas Büyüktimkin 1 Department of Pharmaceutical Chemistry, School of Pharmacy, University of Kansas, Lawrence, KSIntroduction. Fibroblast growth factor-10 (FGF-10), also known as keratinocyte growth factor-2 (KGF-2), is a 208 amino acid polypeptide (M w 19,000) belonging to the FGF family. These structurally related proteins bind to polyanions including heparin and are involved in a variety of physiological and pathological processes [].FGF-10 activities include epithelial cell proliferation and ...

Cory BERKLAND | Cited by 10,556 | of University of Kansas, Kansas (KU) | Read 249 publications | Contact Cory BERKLANDCory Berkland. 2004, Journal of Controlled Release. A thorough understanding of the factors affecting drug release mechanisms from surface-erodible polymer devices is critical to the design of optimal delivery systems. Poly(sebacic anhydride) (PSA) microspheres were loaded with three model drug compounds (rhodamine B, p-nitroaniline and ...Intercellular cell-adhesion molecule-1 (ICAM-1) is up-regulated on the vascular endothelium in response to pro-inflammatory cytokines produced in the synovial cavity of patients with Rheumatoid Arthritis.Cory Berkland 1 , C Russell Middaugh 2 Affiliations 1 a Department of Chemical and Petroleum Engineering and Department of Pharmaceutical Chemistry , The University of Kansas , Lawrence , KS , USA.Brittany L Hartwell 1 , Chad J Pickens 2 , Martin Leon 3 , Cory Berkland 1 2 4 Affiliations 1 Bioengineering Graduate Program, University of Kansas 1520 West 15th Street, Lawrence, Kansas 66045, United States. 2 Department of Pharmaceutical Chemistry, University of Kansas 2095 Constant Avenue ...Sep 17, 2020 · As part of the BME seminar series, join us for this presentation by Cory Berkland, Solon E. Summerfield Distinguished Professorship in the Department of Pharmaceutical Chemistry and in the Department of Chemical Engineering at The University of Kansas. This seminar will be virtual. Register for this event by going here. Abstract: Effective delivery of drugs to therapeutic targets requires an ... Brad Spitz, Nathan Dormer & Cory Berkland are part of Orbis Biosciences leadership, Maria Stecklein Flynn is the CEO.Sep 6, 2014 · The induction of immune response by presentation of antigen on or with immune stimulating “signal” is a primary design metric of vaccines. We rationalized that a similar strategy could also be used to design antigen-SITs to induce tolerance to autoantigen. Both approaches focus on the recognition, attack, and removal of a “foreign ... J Pharm Innov (2010) 5:70–71 DOI 10.1007/s12247-010-9084-0 EDITORIAL Cory Berkland Published online: 16 July 2010 # Springer Science+Business Media, LLC 2010 In the pharmaceutical community, nanotechnology has that particles with a diameter larger than about 10 nm may become the flavor of the day for anything with a size or …Singkome Tima 1 , Siriporn Okonogi 2 , Chadarat Ampasavate 2 , Chad Pickens 3 , Cory Berkland 4 , Songyot Anuchapreeda 5 Affiliations 1 Nanoscience and Nanotechnology Program, Graduate School, Chiang Mai University, Chiang Mai 50200, Thailand.Cory Berkland. The Berkland Lab investigates pharmaceuticals and biomaterials. They aim to understand the transport of pharmaceuticals as a function of physical and …1.. IntroductionInjectable biomaterials that form three-dimensional (3-D) structures in situ are being pursued as tissue engineering scaffolds [1], biosensors [2] and drug delivery systems [3].Colloidal gels composed of oppositely-charged nanoparticles at high concentration can exhibit pseudoplastic behavior facilitating the fabrication of shape-specific macroscale materials with 3-D ...

Recently, lymphocyte function-associated antigen-1 (LFA-1), a primary cell adhesion molecule, has also been investigated for targeting nanoparticles to human leukemic cell line ( 30, 32 ). Lima et al. reported that certain leukemic cells expressed 5-fold more LFA-1 than normal leukocytes ( 32 ). Since LFA-1 is expressed only on leukocytes, it ...

Aug 3, 2015 · Abstract. Antibiotic multi-resistant pneumonia is a risk associated with long term mechanical ventilation. Vancomycin is commonly prescribed for methicillin-resistant staphylococcus aureus infections; however, current formulations of vancomycin are only given intravenously. High doses of vancomycin have been associated with severe renal toxicity. Cory Berkland was associated with Savara Pharmaceuticals in 2019. They may have been associated with this organization before or after this year as well. Savara Pharmaceuticals Business Data 900 S Capital Of Texas Hwy, Ste 150, Austin, Texas, 78746-5436 (512) 961-1891Jian Qian 1 , Cory Berkland 2 Affiliations 1 Department of ... Electronic address: [email protected]. PMID: 31655253 PMCID: PMC6820273 DOI ...Dr. Cory Berkland is Chairman of the Board, President, CEO, and Co-Founder of Bond Biosciences. He is Distinguished Professor at The University of Kansas and has …Qingting Hu, 1 Megan Myers, 1 Wei Fang, 1 Min Yao, 1 Gage Brummer, 1 Justin Hawj, 1 Curtis Smart, 1 Cory Berkland, 2 and Nikki Cheng 1, 3, * Qingting Hu 1 Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USASingkome Tima; Siriporn Okonogi; Chadarat Ampasavate; Chad Pickens; Cory Berkland; Songyot Anuchapreeda: 18-May-2016: Down-regulatory mechanism of mammea E/BB from Mammea siamensis seed extract on Wilms' Tumor 1 expression in K562 cellsSingkome Tima; Siriporn Okonogi; Chadarat Ampasavate; Chad Pickens; Cory Berkland; Songyot Anuchapreeda: 18-Jul-2015: HPMA-based polymeric micelles for curcumin solubilization and inhibition of cancer cell growth: Ornchuma Naksuriya; Yang Shi; Cornelus F. Van Nostrum; Songyot Anuchapreeda; Wim E. Hennink; Siriporn OkonogiA cyclic peptide, cIBR, possesses high affinity for LFA-1, and conjugation to the surface of poly (DL-lactic-co-glycolic acid) nanoparticles can specifically target and deliver the encapsulated agents to T cells expressing LFA-1. The kinetics of targeted nanoparticle uptake by acute lymphoblastic leukemia T cells was investigated by flow ...Visit the main Washington University in St. Louis website 1 Brookings Drive / St. Louis, MO 63130 / wustl.edu

Map of europee.

Bill self today.

Ph.D. Candidate under Dr. Cory Berkland and Dr. Laird Forrest in the Department of Pharmaceutical Chemistry, University of Kansas. Specialized in Peptide-based Delivery Strategies to Enhance ...Ruolin Lu, 1 Chad Groer, 2 Peter A. Kleindl, 1 K. Ryan Moulder, 1 Aric Huang, 1 Jordan R. Hunt, 1 Shuang Cai, 1, 2 Daniel J. Aires, 2, 3 Cory Berkland, 1 and Laird Forrest 1, 2, * Ruolin Lu 1 Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas30‏/05‏/2018 ... 2012 Cory Berkland. 2011 Molly Stevens. 2010 Krish Roy. 2009 Justin Hanes. 2008 Samir Mitragotri. 2007 David Putnam. 2006 Stefaan De Smedt. 2005 ...Nashwa El-Gendy1,3, Warangkana Pornputtapitak1, and Cory Berkland1,2,* 1Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS 66047. ... Fax: (001) 785- 864- 1454. [email protected]. Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to ourAbdulgader A. Baoum1 and Cory J. Berkland1,2,* 1Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS ... Baoum and Berkland Page 3 J Pharm Sci. Author manuscript; available in PMC 2014 October 23. NIH-PA Author Manuscript. gene delivery in vivo28,39-41. One approach for overcoming this limitation was to link theMy research under Dr. Cory Berkland involved the development of an antigen-specific immunotherapy for multiple sclerosis. Specifically, I investigated the cell targeting properties and therapeutic ...Title: PLGA nanoparticle-peptide conjugate effectively targets intercellular cell-adhesion molecule-1: Authors: Na Zhang Chuda Chittasupho Chadarat DuangratJ Pharm Innov (2010) 5:70–71 DOI 10.1007/s12247-010-9084-0 EDITORIAL Cory Berkland Published online: 16 July 2010 # Springer Science+Business Media, LLC 2010 In the pharmaceutical community, nanotechnology has that particles with a diameter larger than about 10 nm may become the flavor of the day for anything with a size or …03‏/04‏/2023 ... ... Cory J Berkland. Affiliations. 1 Bioengineering Program, The University of Kansas, Lawrence, Kansas 66045, United States. 2 HylaPharm ...Joe Scherrer. Executive Director, Henry Edwin Sever Institute Director, Cybersecurity Strategic Initiative Program Director, Graduate Studies in Cybersecurity Management.Nashwa El-Gendy1,3, Warangkana Pornputtapitak1, and Cory Berkland1,2,* 1Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS 66047. ... Fax: (001) 785- 864- 1454. [email protected]. Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our ….

C. Berkland, K. Kim, and D.W. Pack (2004) Controlling double-walled microcapsule shell thickness offers modulated piroxicam release Journal of Biomedical Materials Research 70A(4):576-584 C. Berkland, K. Kim, and D.W. Pack (2004) Uniform double-walled polymer microspheres of controllable shell thickness Journal of Controlled Release, 96(1):101-111pH-sensitive triblock copolymers for efficient siRNA encapsulation and delivery†. Check for updates. Jian Qiana and Cory Berkland*ab. Author affiliations.Veisi, Masoumeh , Johnson, Stephen , Peltier, Karen , Berkland, Cory , Liang, Jenn-Tai , and Reza Barati. "Application of Polyelectrolyte Complex Nanoparticles to Increase the Lifetime of Poly Vinyl Sulfonate Scale Inhibitor." Paper presented at the SPE International Conference and Exhibition on Formation Damage Control, Lafayette, ...Qingting Hu, 1 Megan Myers, 1 Wei Fang, 1 Min Yao, 1 Gage Brummer, 1 Justin Hawj, 1 Curtis Smart, 1 Cory Berkland, 2 and Nikki Cheng 1, 3, * Qingting Hu 1 Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USAI would like to sincerely and gratefully thank my advisor, Dr. Cory Berkland, for all of his support, guidance, patience, understanding, and most importantly, his friendship during my graduate studies at The University of Kansas. I have been fortunately blessed to have an advisor who gave me a great opportunity to develop my own individuality byNumber of Employee Profiles 2. Bond Biosciences has 2 current employee profiles, including Co-founder and Chief Scientific Officer Cory Berkland. Cory Berkland Co-founder and Chief Scientific Officer.Cory Berkland, The University of Kansas, Lawrence, Kansas, United States of America Akhilesh Bhambhani, Merck and Co Inc West Point, Doylestown, Pennsylvania, United States of America Michael Blaber, Florida State University, Tallahassee, Florida, United States of AmericaDec 29, 2017 · J. Daniel Griffin, Martin A. Leon, Jean R. Salash, Michael Shao, Brittany L. Hartwell, Chad J. Pickens, Joshua O. Sestak, Cory Berkland. Acute B-Cell Inhibition by Soluble Antigen Arrays Is Valency-Dependent and Predicts Immunomodulation in Splenocytes. Biomacromolecules 2019, 20 (5) , 2115-2122. Cory berkland, Cory Berkland, PhD, Orbis Biosciences Co-Founder and Chief Scientific Officer, has demonstrated Orbis's technology capabilities for over 15 years. Cory has a ..., My research under Dr. Cory Berkland involved the development of an antigen-specific immunotherapy for multiple sclerosis. Specifically, I investigated the cell targeting properties and therapeutic ..., BME Faculty Directory. Cardiovascular Engineering. Orthopedic Engineering. Women's Health Technologies., Joshua O Sestak 1 , Bradley P Sullivan 1 , Sharadvi Thati 1 , Laura Northrup 1 , Brittany Hartwell 2 , Lorena Antunez 1 , M Laird Forrest 1 , Charlotte M Vines 3 , Teruna J Siahaan 1 , Cory Berkland 4, Burkholderia pseudomallei, the etiological agent responsible for melioidosis, exhibits a great public health toll in its endemic regions. The elevation of B. pseudomallei to a Tier I select agent underscores the urgent need for effective therapeutics and preventatives. The current treatment regimen for melioidosis is suboptimal, requiring an intensive phase of intravenous antibiotic followed ..., Lianjun Shi 1 , Cory Berkland. Affiliation 1 Department of Chemical and Petroleum Engineering, The University of Kansas, Lawrence, KS 66047. PMID: 18797513 PMCID: PMC2537468 DOI: 10.1021/ma070443o Abstract Hollow nanoparticles represent an emerging area of development for the encapsulation of active ingredients. ..., Cory Berkland. 2004, Biomaterials. Improved control of surface micro-and nano-structure may lead to enhanced performance of degradable biomedical devices such as surgical dressings, vascular grafts, tissue engineering scaffolds, sutures, and structures for guided tissue regeneration. An electrohydrodynamic method called flow-limited field ..., 30‏/03‏/2016 ... Cory J Berkland · Michael S Detamore. Google Scholar. Emily Beck · Marilyn Barragan · Madeleine H Tadros · Stevin H Gehrke · Cory J Berkland ..., Prof. Cory Berkland (Chair) Prof. Marylee Southard Prof. Stevin Gehrke Date Approved: iii Abstract: Magnetic nanoparticles that display high saturation magnetization and high magnetic susceptibility with a size less than 200 nm are of great interest for medical applications. Investigations of magnetic nanoparticles have been, Na Zhang; Chuda Chittasupho; Chadarat Duangrat; Teruna J. Siahaan; Cory Berkland: 1-May-2017: Stable curcumin-loaded polymeric micellar formulation for enhancing cellular uptake and cytotoxicity to FLT3 overexpressing EoL-1 leukemic cells: Singkome Tima; Songyot Anuchapreeda; Chadarat Ampasavate; Cory Berkland; Siriporn Okonogi, Alhakamy, Nabil A; Nigatu, Adane S; Berkland, Cory J et al. (2013) Noncovalently associated cell-penetrating peptides for gene delivery applications. Ther Deliv 4:741-57 Alhakamy, Nabil A; Berkland, Cory J (2013) Polyarginine molecular weight determines transfection efficiency of calcium condensed complexes. Mol Pharm 10:1940-8, Cory Berkland Ph.D: Co-Founder, Chief Scientific Officer & Board Member: Bowman Fishback: Co-Founder & Chairman: You're viewing 3 of 7 executive team members. Get the full list » Orbis Biosciences Board Members (8) Name Representing Role Since; 000000 00000000: Self: Co-Founder & Chairman:, Cory Berkland The University of Kansas Verified email at ku.edu. Paulette Spencer Ackers Distinguished Professor, ... M Lazebnik, M Singh, P Glatt, LA Friis, CJ Berkland, MS Detamore. Journal of tissue engineering and regenerative medicine 5 (8), e179-e187, 2011. 80: 2011: Fatigue performance of composite analogue femur constructs under high ..., BME Faculty Directory. Cardiovascular Engineering. Orthopedic Engineering. Women's Health Technologies., Aug 5, 2020 · Cory Berkland is a professor of pharmaceutical chemistry and chemical and petroleum engineering at the University of Kansas. (Berkland Tr. 593) The Court recognized Dr. Berkland as an expert in the preparation and analysis of pharmaceutical formulations. , Cory Berkland The University of Kansas Verified email at ku.edu. Stevin H. Gehrke University of Kansas Verified email at ku.edu. ... M Singh, L Wang, CJ Berkland, MS Detamore. Annals of biomedical engineering 38, 2167-2182, 2010. 136: 2010: Development and quantitative characterization of the precursor rheology of hyaluronic acid hydrogels for ..., Author Berkland, Cory J. (1) Borchard, Gerrit (1) Christensen, Lane (1) Merkle, Hans P. (1) Date Issued 2006 (4) My Account. Login. Statistics. View Usage Statistics View Search Statistics View Workflow Statistics. RSS Feeds. RSS 1.0 RSS 2.0 Atom. Contact KU ScholarWorks. 785-864-8983. KU Libraries 1425 Jayhawk Blvd Lawrence, KS 66045., Cory Berkland, PhD. WIZARD FEATURES. © 2023 DeKosky Lab., Tiffany C. Suekama, Vara Aziz, Zahra Mohammadi, Cory Berkland, Stevin H. Gehrke. Synthesis and characterization of poly( N -vinyl formamide) hydrogels-A potential alternative to polyacrylamide hydrogels. Journal of Polymer Science Part A: Polymer Chemistry 2013, 51 (2) , 435-445, View Cory Berkland's record in Saint Louis, MO including current phone number, address, relatives, background check report, and property record with Whitepages. • -- ..., Cory Berkland, PhD. CEO, BOND BIOSCIENCES. Saint Louis, Missouri, United States. Dr. Berkland serves as the Chairman of the Board, President, Chief Executive Officer (CEO), and Co-Founder of Bond Biosciences. He is taking a partial leave as Distinguished Professor at The University of Kansas to advance the business and to ensure the development ..., Cory Berkland Laird Forrest Michael Hageman Jeff Krise Sue Lunte Russ Middaugh Christian Schöneich Teruna Siahaan John Stobaugh Thomas Tolbert David Volkin Michael Wang Undergraduate Research Program ..., Inventors: Stephen J Johnson, Cory Berkland, Ahmad Moradi-Araghi, Jenn-Tai Liang, Terry M. Christian, Riley B. Needham, Min Cheng, Ying-Ying Lin, Andrew B. Woodside Taste masking drug formulations Patent number: 11026893, Cory Berkland, professor in the Department of Chemical and Petroleum Engineering and the Department of Pharmaceutical Chemistry, received the Jim Baxendale Commercialization Award. ... Berkland is the co-founder of three companies since coming to KU in 2004: Orbis Biosciences, Savara Pharmaceuticals and Orion BioScience. These companies are ..., Copyright 2022 Kinimmune, Inc. | Legal Kinimmune, Inc. 4340 Duncan Ave St. Louis, MO 63110, Vaccine-like Controlled-Release Delivery of an Immunomodulating Peptide to Treat Experimental Autoimmune Encephalomyelitis Barlas Büyüktimkin1, Qun Wang2, Paul Kiptoo1, John M. Stewart1, Cory Berkland1,2, and Teruna J. Siahaan1,* 1Department of Pharmaceutical Chemistry, School of Pharmacy, University of Kansas, Lawrence, KS, Qingting Hu, 1 Megan Myers, 1 Wei Fang, 1 Min Yao, 1 Gage Brummer, 1 Justin Hawj, 1 Curtis Smart, 1 Cory Berkland, 2 and Nikki Cheng 1, 3, * Qingting Hu 1 Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USA, Singkome Tima, Songyot Anuchapreeda, Chadarat Ampasavate, Cory Berkland, Siriporn Okonogi. Stable curcumin-loaded polymeric micellar formulation for enhancing cellular uptake and cytotoxicity to FLT3 overexpressing EoL-1 leukemic cells. European Journal of Pharmaceutics and Biopharmaceutics 2017, 114, 57-68. DOI: …, If delivered as a suspension, such small particles are also prone to particle growth due to Ostwald ripening and can suffer from uncontrolled agglomeration (Berkland, 2010). A major obstacle to inhaled therapeutics is the inability to efficiently deliver large quantities of a drug to the deep lung (Gillian, 2010)., Dr. Hartwell obtained her Ph.D. in biomolecular engineering with Cory Berkland at the University of Kansas as a Madison and Lila Self Graduate Fellow. Her doctoral research focused on developing an antigen-specific immunotherapy to treat multiple sclerosis while determining cellular and molecular mechanisms of tolerance., Author: Susan MacNally Created Date: 08/20/2021 11:09:00 Title: Conflict management plan for Cory Berkland (L0013204-5).DOC Subject: L0013204 / 5 Last modified by, Min Huang 1 , Samadhi N Vitharana, Laura J Peek, Tina Coop, Cory Berkland. Affiliation 1 Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047, USA. PMID: 17428030 DOI: 10.1021/bm061211k Abstract Angiogenesis has long been a desired therapeutic approach to improve clinical outcomes of conditions typified by ..., Cory Berkland View MOF on the other hand, Wuttke and others (Ettlinger et al., 2022) argue that shape or topology might not have a major role to play in overall toxicity, citing a lack of evidence ...